<TOP>
	<NUM>1</NUM>
	<disease>melanoma</disease>
	<gene>BRAF (V600E)</gene>
	<demographic>64-year-old male</demographic>
</TOP>
<TOP>
	<NUM>2</NUM>
	<disease>melanoma</disease>
	<gene>BRAF (V600K)</gene>
	<demographic>54-year-old male</demographic>
</TOP>
<TOP>
	<NUM>3</NUM>
	<disease>melanoma</disease>
	<gene>BRAF (V600R)</gene>
	<demographic>80-year-old male</demographic>
</TOP>
<TOP>
	<NUM>4</NUM>
	<disease>melanoma</disease>
	<gene>BRAF (K601E)</gene>
	<demographic>38-year-old male</demographic>
</TOP>
<TOP>
	<NUM>5</NUM>
	<disease>melanoma</disease>
	<gene>BRAF (V600E), PTEN loss of function</gene>
	<demographic>57-year-old male</demographic>
</TOP>
<TOP>
	<NUM>6</NUM>
	<disease>melanoma</disease>
	<gene>BRAF (V600E), NRAS (Q61R)</gene>
	<demographic>67-year-old male</demographic>
</TOP>
<TOP>
	<NUM>7</NUM>
	<disease>melanoma</disease>
	<gene>BRAF amplification</gene>
	<demographic>61-year-old male</demographic>
</TOP>
<TOP>
	<NUM>8</NUM>
	<disease>melanoma</disease>
	<gene>NRAS (Q61R)</gene>
	<demographic>63-year-old female</demographic>
</TOP>
<TOP>
	<NUM>9</NUM>
	<disease>melanoma</disease>
	<gene>NRAS (Q61L)</gene>
	<demographic>34-year-old female</demographic>
</TOP>
<TOP>
	<NUM>10</NUM>
	<disease>melanoma</disease>
	<gene>KIT (L576P)</gene>
	<demographic>65-year-old female</demographic>
</TOP>
<TOP>
	<NUM>11</NUM>
	<disease>melanoma</disease>
	<gene>KIT (L576P), KIT amplification</gene>
	<demographic>56-year-old female</demographic>
</TOP>
<TOP>
	<NUM>12</NUM>
	<disease>melanoma</disease>
	<gene>KIT (K642E)</gene>
	<demographic>62-year-old female</demographic>
</TOP>
<TOP>
	<NUM>13</NUM>
	<disease>melanoma</disease>
	<gene>KIT (N822Y)</gene>
	<demographic>39-year-old female</demographic>
</TOP>
<TOP>
	<NUM>14</NUM>
	<disease>melanoma</disease>
	<gene>KIT amplification</gene>
	<demographic>66-year-old female</demographic>
</TOP>
<TOP>
	<NUM>15</NUM>
	<disease>melanoma</disease>
	<gene>NF1 truncation</gene>
	<demographic>70-year-old male</demographic>
</TOP>
<TOP>
	<NUM>16</NUM>
	<disease>melanoma</disease>
	<gene>NTRK1 rearrangement</gene>
	<demographic>60-year-old male</demographic>
</TOP>
<TOP>
	<NUM>17</NUM>
	<disease>melanoma</disease>
	<gene>TP53 loss of function</gene>
	<demographic>72-year-old male</demographic>
</TOP>
<TOP>
	<NUM>18</NUM>
	<disease>melanoma</disease>
	<gene>tumor cells with &gt;50% membranous PD-L1 expression</gene>
	<demographic>48-year-old female</demographic>
</TOP>
<TOP>
	<NUM>19</NUM>
	<disease>melanoma</disease>
	<gene>tumor cells negative for PD-L1 expression</gene>
	<demographic>73-year-old male</demographic>
</TOP>
<TOP>
	<NUM>20</NUM>
	<disease>melanoma</disease>
	<gene>high tumor mutational burden</gene>
	<demographic>86-year-old female</demographic>
</TOP>
<TOP>
	<NUM>21</NUM>
	<disease>melanoma</disease>
	<gene>extensive tumor infiltrating lymphocytes</gene>
	<demographic>49-year-old male</demographic>
</TOP>
<TOP>
	<NUM>22</NUM>
	<disease>melanoma</disease>
	<gene>no tumor infiltrating lymphocytes</gene>
	<demographic>74-year-old female</demographic>
</TOP>
<TOP>
	<NUM>23</NUM>
	<disease>melanoma</disease>
	<gene>PTEN loss of function</gene>
	<demographic>68-year-old male</demographic>
</TOP>
<TOP>
	<NUM>24</NUM>
	<disease>melanoma</disease>
	<gene>APC loss of function</gene>
	<demographic>47-year-old male</demographic>
</TOP>
<TOP>
	<NUM>25</NUM>
	<disease>melanoma</disease>
	<gene>high serum LDH levels</gene>
	<demographic>69-year-old female</demographic>
</TOP>
<TOP>
	<NUM>26</NUM>
	<disease>colorectal cancer</disease>
	<gene>NRAS</gene>
	<demographic>49-year-old male</demographic>
</TOP>
<TOP>
	<NUM>27</NUM>
	<disease>medullary thyroid carcinoma</disease>
	<gene>RET</gene>
	<demographic>45-year-old female</demographic>
</TOP>
<TOP>
	<NUM>28</NUM>
	<disease>neuroblastoma</disease>
	<gene>ALK</gene>
	<demographic>4-year-old female</demographic>
</TOP>
<TOP>
	<NUM>29</NUM>
	<disease>esophageal cancer</disease>
	<gene>EGFR</gene>
	<demographic>67-year-old male</demographic>
</TOP>
<TOP>
	<NUM>30</NUM>
	<disease>lung cancer</disease>
	<gene>ROS1</gene>
	<demographic>71-year-old female</demographic>
</TOP>
<TOP>
	<NUM>31</NUM>
	<disease>head and neck squamous cell carcinoma</disease>
	<gene>CDKN2A</gene>
	<demographic>64-year-old male</demographic>
</TOP>
<TOP>
	<NUM>32</NUM>
	<disease>leukemia</disease>
	<gene>ABL1</gene>
	<demographic>4-year-old female</demographic>
</TOP>
<TOP>
	<NUM>33</NUM>
	<disease>gastric cancer</disease>
	<gene>EGFR</gene>
	<demographic>60-year-old female</demographic>
</TOP>
<TOP>
	<NUM>34</NUM>
	<disease>sarcoma</disease>
	<gene>MDM2</gene>
	<demographic>78-year-old female</demographic>
</TOP>
<TOP>
	<NUM>35</NUM>
	<disease>breast cancer</disease>
	<gene>CDKN2A</gene>
	<demographic>73-year-old female</demographic>
</TOP>
<TOP>
	<NUM>36</NUM>
	<disease>lung cancer</disease>
	<gene>ERBB2</gene>
	<demographic>49-year-old female</demographic>
</TOP>
<TOP>
	<NUM>37</NUM>
	<disease>non-small cell carcinoma</disease>
	<gene>MET</gene>
	<demographic>68-year-old male</demographic>
</TOP>
<TOP>
	<NUM>38</NUM>
	<disease>cholangiocarcinoma</disease>
	<gene>IDH1</gene>
	<demographic>50-year-old male</demographic>
</TOP>
<TOP>
	<NUM>39</NUM>
	<disease>anaplastic large cell lymphoma</disease>
	<gene>ALK</gene>
	<demographic>18-year-old male</demographic>
</TOP>
<TOP>
	<NUM>40</NUM>
	<disease>breast cancer</disease>
	<gene>ERBB2</gene>
	<demographic>56-year-old female</demographic>
</TOP>
<TOP>
	<NUM>41</NUM>
	<disease>papillary thyroid carcinoma</disease>
	<gene>NTRK1</gene>
	<demographic>46-year-old female</demographic>
</TOP>
<TOP>
	<NUM>42</NUM>
	<disease>glioblastoma</disease>
	<gene>CDK6</gene>
	<demographic>84-year-old male</demographic>
</TOP>
<TOP>
	<NUM>43</NUM>
	<disease>basal cell carcinoma</disease>
	<gene>PTCH1</gene>
	<demographic>56-year-old female</demographic>
</TOP>
<TOP>
	<NUM>44</NUM>
	<disease>glioma</disease>
	<gene>BRAF</gene>
	<demographic>82-year-old male</demographic>
</TOP>
<TOP>
	<NUM>45</NUM>
	<disease>thyroid cancer</disease>
	<gene>BRAF</gene>
	<demographic>40-year-old female</demographic>
</TOP>
<TOP>
	<NUM>46</NUM>
	<disease>lung cancer</disease>
	<gene>FGFR1</gene>
	<demographic>57-year-old male</demographic>
</TOP>
<TOP>
	<NUM>47</NUM>
	<disease>prostate cancer</disease>
	<gene>PTEN</gene>
	<demographic>70-year-old male</demographic>
</TOP>
<TOP>
	<NUM>48</NUM>
	<disease>adenoid cystic carcinoma</disease>
	<gene>KIT</gene>
	<demographic>58-year-old female</demographic>
</TOP>
<TOP>
	<NUM>49</NUM>
	<disease>acute myeloid leukemia</disease>
	<gene>IDH1</gene>
	<demographic>1-year-old male</demographic>
</TOP>
<TOP>
	<NUM>50</NUM>
	<disease>acute myeloid leukemia</disease>
	<gene>FLT3</gene>
	<demographic>13-year-old male</demographic>
</TOP>
